ASHLEY GILLILAND: Open Payments
NPI 1215680038 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 9 payments from 7 companies in 2025. Trend: 2023 $620 · 2024 $616 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Ceribell, Inc. | 1 | $30 |
| Stryker Corporation | 1 | $29 |
| Corium, LLC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: ELIQUIS, XIFAXAN, POCKET EEG DEVICE, FLOWTRIEVER, Azstarys, FANAPT, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
